Given the known functions of these pathways—JAK-STAT signaling modulates anti-tumor immune responses, and NF-κB is involved in inflammation and immune regulation —we hypothesize that they may synergistically affect HLA-II expression in KYSE270 and the tumor microenvironment. Here, NFKB1 is linked to neoplasm.